Acute changes in blood pressure in patients with neuroblastoma treated with 131I-metaiodobenzylguanidine (MIBG)

Pediatric Blood and Cancer

Volumn 60, Issue 9, 2013, Pages 1424-1430

  Wong, Thalia ^a   Matthay, Katherine K ^a   John Boscardin, W ^a   Hawkins, Randall A ^a   Brakeman, Paul R ^a   Dubois, Steven G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hypertension; MIBG; Neuroblastoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE; (3 IODOBENZYL)GUANIDINE I 131; IRINOTECAN; NIFEDIPINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CANCER COMBINATION CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG INFUSION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; NEUROBLASTOMA; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

HYPERTENSION; MIBG; NEUROBLASTOMA;

3-IODOBENZYLGUANIDINE; ADOLESCENT; AGE FACTORS; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERTENSION; INFANT; MALE; NEUROBLASTOMA; NIFEDIPINE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TIME FACTORS; VASODILATOR AGENTS;

EID: 84880361970     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24551     Document Type: Article

References (19)

1. Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999; 341:1165-1173.
2. DuBois SG, Matthay KK. Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma. Nucl Med Biol 2008; 35:S35-S48.
3. Matthay KK, Yanik G, Messina J, et al. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma. J Clin Oncol 2007; 25:1054-1060.
4. Madre C, Orbach D, Baudouin V, et al. Hypertension in childhood cancer: A frequent complication of certain tumor sites. J Pediatr Hematol Oncol 2006; 28:659-664.
5. Currie G, Freel EM, Perry CG, et al. Disorders of blood pressure regulation-role of catecholamine biosynthesis, release, and metabolism. Curr Hypertens Rep 2012; 14:38-45.
6. Lashford LS, Lewis IJ, Fielding SL, et al. Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: A United Kingdom Children's Cancer Study Group investigation. J Clin Oncol 1992; 10:1889-1896.
7. Kosmin MA, Bomanji JB, Cork NJ, et al. Hypertension complicating 131I-meta-iodobenzylguanidine therapy for neuroblastoma. Eur J Nucl Med Mol Imaging 2012; 39:597-601.
8. DuBois SG, Chesler L, Groshen S, et al. Phase I study of vincristine, irinotecan, and (1)(3)(1)I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: A new approaches to neuroblastoma therapy trial. Clin Cancer Res 2012; 18:2679-2686.
9. Matthay KK, Tan JC, Villablanca JG, et al. Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: A new approaches to Neuroblastoma Therapy Consortium Study. J Clin Oncol 2006; 24:500-506.
10. Matthay KK, Quach A, Huberty J, et al. 131I-Metaiodobenzylguanidine (131I-MIBG) double infusion with autologous stem cell. Rescue for neuroblastoma: A new approaches to neuroblastoma therapy (NANT) phase I study. J Clin Oncol 2009; 27:1020-1025.
11. Matthay KK, Weiss B, Villablanca JG, et al. Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: New approaches to neuroblastoma therapy consortium trial. J Nucl Med 2012; 53:1155-1163.
12. Matthay KK, DeSantes K, Hasegawa B, et al. Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma. J Clin Oncol 1998; 16:229-236.
13. National Heart Blood L, Institute. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents: National Institutes of Health; 2005. Report.
14. National Heart Blood L, Institute. What is High Blood Pressure?: National Institutes of Health; 2011. Report.
15. White WB, Dey HM, Schulman P. Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension. Am Heart J 1989; 118:782-795.
16. Cole TJ, Bellizzi MC, Flegal KM, et al. Establishing a standard definition for child overweight and obesity worldwide: International survey. BMJ 2000; 320:1240-1243.
17. Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20:629-637.
18. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470.
19. Flynn JT, Mitsnefes M, Pierce C, et al. Blood pressure in children with chronic kidney disease: A report from the chronic kidney disease in children study. Hypertension 2008; 52:631-637.